(Nashville, Tennessee / September 10, 2015) The law firm of Baker Donelson represented Knoxville, Tennessee-based Provectus Biopharmaceuticals, Inc., a clinical-stage oncology and dermatology biopharmaceutical company, in a $13 million public offering of common stock and warrants. Baker Donelson also advised the company in connection with listing the warrants issued in the offering on the NYSE MKT.
The Baker Donelson team representing Provectus included shareholder Tonya Mitchem Grindon and associates Christopher Douse and Jimmie B. Strong, all from the Firm's Nashville office.